Literature DB >> 20006706

The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells.

Kumiko Goto1, Yoshihiko Chiba, Kimihiko Matsusue, Yoshiyuki Hattori, Yoshie Maitani, Hiroyasu Sakai, Shioko Kimura, Miwa Misawa.   

Abstract

RhoA protein is involved in the Ca(2+) sensitization of bronchial smooth muscle (BSM) contraction, and an upregulation of RhoA in BSMs has been suggested in allergic bronchial asthma. However, the mechanism of upregulation of RhoA remains poorly understood. In the present study, the transcriptional regulation of human RhoA gene was investigated in cultured human BSM cells stimulated with IL-13 and TNF-alpha, both of which have an ability to upregulate RhoA protein. Luciferase-based assay showed that the RhoA promoter activity was augmented by both IL-13 and TNF-alpha. The deletion studies revealed a significant level of promoter activity between the 112 bp upstream and the transcription start site, which contains the STAT6 (78-70 bp upstream) and NF-kappaB (84-74 bp upstream) binding regions. The promoter activity was also decreased significantly by the mutations of these regions. Thus, the current study for the first time characterized the transcriptional regulation of the human RhoA gene. The findings also suggest that STAT6 and NF-kappaB are important for the upregulation of RhoA in human BSM induced by IL-13 and TNF-alpha, both of which are major cytokines in the pathogenesis of allergic bronchial asthma. (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006706      PMCID: PMC3486725          DOI: 10.1016/j.phrs.2009.12.001

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  46 in total

1.  STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts.

Authors:  J Hoeck; M Woisetschläger
Journal:  J Immunol       Date:  2001-04-01       Impact factor: 5.422

2.  Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm.

Authors:  H Shimokawa; M Seto; N Katsumata; M Amano; T Kozai; T Yamawaki; K Kuwata; T Kandabashi; K Egashira; I Ikegaki; T Asano; K Kaibuchi; A Takeshita
Journal:  Cardiovasc Res       Date:  1999-09       Impact factor: 10.787

3.  Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension.

Authors:  Y Mukai; H Shimokawa; T Matoba; T Kandabashi; S Satoh; J Hiroki; K Kaibuchi; A Takeshita
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

4.  Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations.

Authors:  J Prieto; C Lensmar; A Roquet; I van der Ploeg; D Gigliotti; A Eklund; J Grunewald
Journal:  Respir Med       Date:  2000-08       Impact factor: 3.415

5.  Augmented acetylcholine-induced, Rho-mediated Ca2+ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats.

Authors:  Y Chiba; Y Takada; S Miyamoto; M MitsuiSaito; H Karaki; M Misawa
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

6.  Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm.

Authors:  M Sato; E Tani; H Fujikawa; K Kaibuchi
Journal:  Circ Res       Date:  2000-08-04       Impact factor: 17.367

7.  Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta.

Authors:  T Kandabashi; H Shimokawa; K Miyata; I Kunihiro; Y Kawano; Y Fukata; T Higo; K Egashira; S Takahashi; K Kaibuchi; A Takeshita
Journal:  Circulation       Date:  2000-03-21       Impact factor: 29.690

8.  Tumor necrosis factor-alpha (TNF-alpha) induces upregulation of RhoA via NF-kappaB activation in cultured human bronchial smooth muscle cells.

Authors:  Kumiko Goto; Yoshihiko Chiba; Hiroyasu Sakai; Miwa Misawa
Journal:  J Pharmacol Sci       Date:  2009-07-14       Impact factor: 3.337

9.  Interleukin-13 augments bronchial smooth muscle contractility with an up-regulation of RhoA protein.

Authors:  Yoshihiko Chiba; Shuji Nakazawa; Michiko Todoroki; Koji Shinozaki; Hiroyasu Sakai; Miwa Misawa
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-07       Impact factor: 6.914

10.  Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells.

Authors:  Yoshihiko Chiba; Miki Tanabe; Kumiko Goto; Hiroyasu Sakai; Miwa Misawa
Journal:  Am J Respir Crit Care Med       Date:  2009-07-30       Impact factor: 21.405

View more
  18 in total

1.  Farnesyltransferase Inhibition Exacerbates Eosinophilic Inflammation and Airway Hyperreactivity in Mice with Experimental Asthma: The Complex Roles of Ras GTPase and Farnesylpyrophosphate in Type 2 Allergic Inflammation.

Authors:  Jennifer M Bratt; Kevin Y Chang; Michelle Rabowsky; Lisa M Franzi; Sean P Ott; Simone Filosto; Tzipora Goldkorn; Muhammad Arif; Jerold A Last; Nicholas J Kenyon; Amir A Zeki
Journal:  J Immunol       Date:  2018-04-27       Impact factor: 5.422

2.  Hyaluronan mediates airway hyperresponsiveness in oxidative lung injury.

Authors:  Ahmed Lazrak; Judy Creighton; Zhihong Yu; Svetlana Komarova; Stephen F Doran; Saurabh Aggarwal; Charles W Emala; Vandy P Stober; Carol S Trempus; Stavros Garantziotis; Sadis Matalon
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-03-06       Impact factor: 5.464

Review 3.  Transcriptional and post-transcriptional regulation of the genes encoding the small GTPases RhoA, RhoB, and RhoC: implications for the pathogenesis of human diseases.

Authors:  Eirini Nomikou; Melina Livitsanou; Christos Stournaras; Dimitris Kardassis
Journal:  Cell Mol Life Sci       Date:  2018-03-02       Impact factor: 9.261

Review 4.  Halogen-Induced Chemical Injury to the Mammalian Cardiopulmonary Systems.

Authors:  Dylan R Addis; Saurabh Aggarwal; Ahmed Lazrak; Tamas Jilling; Sadis Matalon
Journal:  Physiology (Bethesda)       Date:  2021-09-01

5.  Mfge8 suppresses airway hyperresponsiveness in asthma by regulating smooth muscle contraction.

Authors:  Makoto Kudo; S M Amin Khalifeh Soltani; Stephen A Sakuma; William McKleroy; Ting-Hein Lee; Prescott G Woodruff; Jae Woo Lee; Katherine Huang; Chun Chen; Mehrdad Arjomandi; Xiaozhu Huang; Kamran Atabai
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-26       Impact factor: 11.205

6.  Loss of regulator of G protein signaling 5 promotes airway hyperresponsiveness in the absence of allergic inflammation.

Authors:  Nariman A Balenga; William Jester; Meiqi Jiang; Reynold A Panettieri; Kirk M Druey
Journal:  J Allergy Clin Immunol       Date:  2014-03-22       Impact factor: 10.793

7.  IL-17A produced by αβ T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction.

Authors:  Makoto Kudo; Andrew C Melton; Chun Chen; Mary B Engler; Katherine E Huang; Xin Ren; Yanli Wang; Xin Bernstein; John T Li; Kamran Atabai; Xiaozhu Huang; Dean Sheppard
Journal:  Nat Med       Date:  2012-03-04       Impact factor: 53.440

Review 8.  RGS proteins, GRKs, and beta-arrestins modulate G protein-mediated signaling pathways in asthma.

Authors:  Nathalie Fuentes; Morgan McCullough; Reynold A Panettieri; Kirk M Druey
Journal:  Pharmacol Ther       Date:  2021-02-15       Impact factor: 13.400

Review 9.  Hyaluronan and halogen-induced airway hyperresponsiveness and lung injury.

Authors:  Ahmed Lazrak; Weifeng Song; Ting Zhou; Saurabh Aggarwal; Tamas Jilling; Stavros Garantziotis; Sadis Matalon
Journal:  Ann N Y Acad Sci       Date:  2020-06-23       Impact factor: 6.499

10.  Gene silencing of SOCS3 by siRNA intranasal delivery inhibits asthma phenotype in mice.

Authors:  Ma Paz Zafra; Carla Mazzeo; Cristina Gámez; Ainara Rodriguez Marco; Ana de Zulueta; Veronica Sanz; Izaskun Bilbao; Jesús Ruiz-Cabello; Jose M Zubeldia; Victoria del Pozo
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.